Department of Clinical Laboratory, Jiangsu Cancer Hospital, Nanjing, Jiangsu 210009, P.R. China.
Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12437. Epub 2021 Sep 15.
HOXC10 and mitochondrial fission regulator 2 (MTFR2) have been reported to be abnormally expressed in multiple types of cancer tissues. However, the effects of HOXC10 and MTFR2 on colorectal cancer (CRC) remain poorly understood. Therefore, the present study aimed to investigate the expression of HOXC10 and MTFR2 in CRC tissues and cells, and analyze their effects on CRC cell proliferation, invasion and migration. Reverse transcription‑quantitative PCR and western blotting were used to detect the expression levels of MTFR2 and HOXC10 in tissues and cells. To investigate the association between MTFR2 and HOXC10, short hairpin RNA‑MTFR2 and overexpression vector‑HOXC10 were transfected into the cells, respectively. Furthermore, western blotting was performed to detect the expression levels of invasion‑associated proteins. The proliferation, clone formation, invasion and migration of colorectal cancer cells were in turn analyzed by the Cell Counting Kit‑8, clone formation, wound healing and Transwell assays. Japan Automotive Software Platform and Architecture software predicted the binding sites between HOXC10 and MTFR2, which was confirmed by the dual‑luciferase reporter assay and chromatin immunoprecipitation. The present study demonstrated that HOXC10 and MTFR2 mRNA and protein expression levels were significantly upregulated in CRC tissues and cells. MTFR2 knockdown significantly inhibited CRC cell proliferation, clone formation, invasion and migration. Furthermore, HOXC10 was shown to interact with MTFR2. HOXC10 overexpression was able to significantly reverse the inhibitory effects of MTFR2 knockdown on CRC cells. In conclusion, HOXC10 overexpression activated MTFR2 expression to enhance the proliferation, clone formation, invasion and migration of CRC cells.
HOXC10 和线粒体裂变调节剂 2(MTFR2)已被报道在多种类型的癌症组织中异常表达。然而,HOXC10 和 MTFR2 对结直肠癌(CRC)的影响仍知之甚少。因此,本研究旨在探讨 HOXC10 和 MTFR2 在 CRC 组织和细胞中的表达,并分析它们对 CRC 细胞增殖、侵袭和迁移的影响。采用逆转录-定量 PCR 和 Western blot 检测 MTFR2 和 HOXC10 在组织和细胞中的表达水平。为了研究 MTFR2 和 HOXC10 之间的关联,分别将短发夹 RNA-MTFR2 和过表达载体-HOXC10 转染到细胞中。此外,Western blot 检测侵袭相关蛋白的表达水平。依次通过细胞计数试剂盒-8、克隆形成、划痕愈合和 Transwell 分析检测结直肠癌细胞的增殖、克隆形成、侵袭和迁移。日本汽车软件平台和架构软件预测了 HOXC10 和 MTFR2 之间的结合位点,双荧光素酶报告基因检测和染色质免疫沉淀实验验证了这一点。本研究表明,HOXC10 和 MTFR2 mRNA 和蛋白表达水平在 CRC 组织和细胞中显著上调。MTFR2 敲低显著抑制 CRC 细胞增殖、克隆形成、侵袭和迁移。此外,HOXC10 与 MTFR2 相互作用。HOXC10 过表达能够显著逆转 MTFR2 敲低对 CRC 细胞的抑制作用。综上所述,HOXC10 过表达激活 MTFR2 表达,增强 CRC 细胞的增殖、克隆形成、侵袭和迁移。